- Monotherapy data from higher-dose cohorts in both CHIRON and THETIS and combination data from THETIS Cohort B expected in 2H 2022 - LONDON, May 09, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc ...
- Monotherapy data from higher-dose cohorts in both CHIRON and THETIS and combination data from THETIS Cohort B expected in 2H 2022 - “Dosing the first patient in CHIRON with cNeT from our higher-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results